loader

AbCellera Biologics Inc.

NASDAQ:ABCL
Press Releases

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Interactive Chart

×